P
Peter C. Taylor
Researcher at University of Oxford
Publications - 397
Citations - 19020
Peter C. Taylor is an academic researcher from University of Oxford. The author has contributed to research in topics: Rheumatoid arthritis & Arthritis. The author has an hindex of 63, co-authored 359 publications receiving 16347 citations. Previous affiliations of Peter C. Taylor include HealthPartners & University of Cambridge.
Papers
More filters
Journal ArticleDOI
A mass in the left groin: an infected pseudoaneurysm
TL;DR: Take the picture quiz and find out how much you know about these iconic images of the United States.
Journal ArticleDOI
Decarbonisation strategies in industry: going beyond clusters
TL;DR: In this article , a mixed methods approach is used to provide the first analysis of the issues facing dispersed industrial sites on their route to decarbonisation and to suggest solutions to the challenges they face.
Journal ArticleDOI
Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors.
Esben Malm,Esben Malm,Sabrina Mai Nielsen,Sabrina Mai Nielsen,Johannes Berg,Johannes Berg,John P. A. Ioannidis,Daniel E. Furst,Josef S Smolen,Peter C. Taylor,Lars Erik Kristensen,Simon Tarp,Torkell Ellingsen,Robin Christensen,Robin Christensen +14 more
TL;DR: In this paper, the authors search MEDLINE (via PubMed) for systematic reviews published since April 2015 and all Cochrane reviews and assess risk of bias in individual trials using a modified Cochrane RoB tool, and estimate the potentially causal harm effects related to the experimental intervention compared with control comparator as risk ratios, and heterogeneity across randomised comparisons will be assessed statistically and evaluated as inconsistency using the I2 Index.
Journal ArticleDOI
Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe
Peter C. Taylor,Bruno Fautrel,Yves Piette,Susana Romero-Yuste,Jasper C A Broen,M. Welcker,O. Howell,Elke Rottier,Monia Zignani,Katrien Van Beneden,Roberto Caporali,Rieke Alten +11 more
TL;DR: In this article , the authors investigated the use of T2T for RA in a real-world setting across Europe and found that only 66.6% of patients were reported by their physician to be managed using a T2Ts approach.
Original article Variation in the use of biologics in the management of rheumatoid arthritis across the UK
TL;DR: In this article, the authors describe treatment patterns, adherence to guidance and outcomes at hospital/regional level in the UK for rheumatoid arthritis patients, including conventional synthetic disease-modifying antirheumatic drugs (sDMARDs) and newer biologic DMARDs (biologics).